Drug Trial Radar · NCT05983770
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
Last checked: Nov 19, 2026Latest source record: Jul 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
127
Actual
Start
Aug 30, 2023
Primary completion
Sep 11, 2025
Study completion Sep 25, 2025
Sponsor
- Lead sponsor
- Eledon PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Aug 9, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety and efficacy of AT-1501 compared with tacrolimus in patients undergoing kidney transplantation.
Conditions
- Kidney Transplant Rejection
Interventions
AT-1501Drug
IV infusions of AT-1501 20 mg/kg over 1 hour.
TacrolimusDrug
Tacrolimus will be administered BID, targeting a whole blood trough concentration of 6-12 ng/mL until Month 6, and 6-8 ng/mL thereafter.
Primary outcomes
What the sponsor says the trial is designed to measure.
- eGFR at 12 monthsTime frame: Assessed from date of transplant through Day 364 (Month 12)
Locations
43 sites in 7 countries. Site status is shown where the registry gives one.
University of California Los Angeles
Los Angeles, California
Keck School of Medicine of USC
Los Angeles, California
University of California, Irvine Medical Center
Orange, California
University of California, Davis Medical Center
Sacramento, California
Medstar Georgetown University Hospital
Washington D.C., District of Columbia
Tampa General Hospital
Tampa, Florida
Emory University Hospital
Atlanta, Georgia
Augusta University
Augusta, Georgia
University of Chicago
Chicago, Illinois
Loyola University Medical Center
Maywood, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Tulane Medical Center
New Orleans, Louisiana
Johns Hopkins University
Baltimore, Maryland
Massachusetts General Hospita;
Boston, Massachusetts
Henry Ford Health System
Detroit, Michigan
University of Minnesota Medical Center
Minneapolis, Minnesota
Mayo Clinic
Rochester, Minnesota
Washington University in St. Louis
St Louis, Missouri
University of Nebraska Medical Center
Omaha, Nebraska
New York University Langone Health - Tisch Hospital
New York, New York
Duke University Medical Center
Durham, North Carolina
University of Cincinnati Medical Center
Cincinnati, Ohio
University of Pittsburgh Medical Center
Harrisburg, Pennsylvania
UT Southwestern
Dallas, Texas
Virginia Commonwealth University
Richmond, Virginia
University of Washington Medical Center
Seattle, Washington
University of Wisconsin Health
Madison, Wisconsin
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Fiona Stanley Hospital
Perth, Western Australia, Australia
Fundação Oswaldo Ramos - Hospital do Rim
São Paulo, Brazil
Hospital das Clínicas da Faculdade de Medicina de São Paulo
São Paulo, Brazil
St. Paul's Hospital
Vancouver, British Columbia, Canada
Groupe Hospitalier Pellegrin
Bordeaux, France
CHU Grenoble-Alpes - Hopital Nord Michallon
Grenoble, France
Centre Hospitalier Universitaire Dupuytren
Limoges, France
CHU de Toulouse - Hopital de Rangueil
Toulouse, France
CHRU Tours - Hopital Bretonneau
Tours, France
Charite Universitatsmedizin Berlin
Berlin, Germany
Hospital del Mar - Parc de Salut Mar
Barcelona, Spain
Hospital Universitari Vall d'Hebron
Barcelona, Spain
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.